Halozyme Appoints New General Counsel
“Halozyme Therapeutics, Inc. announced that Mark Snyder has been appointed senior vice president, general counsel, chief compliance officer and corporate secretary, Mr. Snyder will succeed Masaru Matsuda, who is stepping down to pursue another opportunity. Mr. Snyder brings almost thirty years,” reports PR Newswire in their blog.
“Over his career he has led and played key roles in a broad range of intellectual property, licensing, regulatory, anti-trust and litigation matters. Most recently Mr. Snyder served as senior vice president, deputy general counsel, litigation for Qualcomm Incorporated, a large, public, multinational wireless technology company with more.”